Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2021

View Archived Issues

Cosegregation powerfully classifies BRCA 1/2 variants

A separable microneedle patch improves delivery and storage of COVID-19 DNA nanovaccines

A large-scale analysis of loss of imprinting in naive and primed human pluripotent stem cells

Hybrid stem cell spheroids may advance stem cell-based therapies for CNS diseases and disorders

Researchers develop a murine model of retinal disease

NR5A2 as pharmacological target for nervous system malignancies

Purdue Research Foundation patents PD-1/PD-L1 interaction inhibitors

North China Pharmaceutical Group Semisyntech divulges GPX4 inhibitors

Zoetis Services identifies IL-1beta, IL-6 and TNF-alpha production inhibitors

Researchers synthesize new CDK inhibitors

Verge Analytics discovers new PIKfyve inhibitors

Study of APOE3 gene variant points to APOE aggregation as a target for treating dementia

VRDN-002 demonstrates promising PK profile in nonhuman primates

THRB agonist reduces aggressive phenotype in anaplastic thyroid cancer

Thymosin beta4 reverses cognitive impairment in mouse model of AD

RAC1 predicts dabrafenib resistance in papillary thyroid cancer

Amgen and Neumora collaborate in neuropsychiatric and neurodegenerative diseases

Chronic myeloid leukemia therapy may be enhanced by ULK1 inhibition

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...